A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Clinical trial NCT00531804 · COMPLETED

Trial details

NCT number: NCT00531804
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2006-12-01
Primary completion: 2010-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.